Role of flavonoids in intestinal tight junction regulation

Journal of Nutritional Biochemistry

Volumn 22, Issue 5, 2011, Pages 401-408

  Suzuki, Takuya ^a,b,c   Hara, Hiroshi ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Epigallocatechin gallate; Flavonoid; Genistein; Myricetin; Quercetin; Tight junction

Indexed keywords

EPIGALLOCATECHIN GALLATE; FLAVONOID; GENISTEIN; MYRICETIN; QUERCETIN;

DOSE RESPONSE; HUMAN; INTESTINE; INTESTINE ABSORPTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; REVIEW; TIGHT JUNCTION;

ANIMALS; ANTIOXIDANTS; CATECHIN; DIET; FLAVONOIDS; GENISTEIN; HUMANS; INTESTINAL MUCOSA; MEMBRANE PROTEINS; PHOSPHORYLATION; QUERCETIN; TIGHT JUNCTIONS;

ENTEROBACTERIACEAE; GLYCINE MAX;

EID: 79954604708     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.08.001     Document Type: Review

References (73)

1. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009, 9:799-809.
2. Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993, 123:1777-1788.
3. Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998, 141:1539-1550.
4. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998, 142:117-127.
5. Ikenouchi J., Furuse M., Furuse K., Sasaki H., Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005, 171:939-945.
6. Gonzalez-Mariscal L., Betanzos A., Nava P., Jaramillo B.E. Tight junction proteins. Prog Biophys Mol Biol 2003, 81:1-44.
7. Stuart R.O., Nigam S.K. Regulated assembly of tight junctions by protein kinase C. Proc Natl Acad Sci U S A 1995, 92:6072-6076.
8. Suzuki T., Elias B.C., Seth A., Shen L., Turner J.R., Giorgianni F., et al. PKC eta regulates occludin phosphorylation and epithelial tight junction integrity. Proc Natl Acad Sci U S A 2009, 106:61-66.
9. Nunbhakdi-Craig V., Machleidt T., Ogris E., Bellotto D., White C.L., Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 2002, 158:967-978.
10. Seth A., Sheth P., Elias B.C., Rao R. Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. J Biol Chem 2007, 282:11487-11498.
11. Sheth P., Basuroy S., Li C., Naren A.P., Rao R.K. Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J Biol Chem 2003, 278:49239-49245.
12. Jenkins R.T., Jones D.B., Goodacre R.L., Collins S.M., Coates G., Hunt R.H., et al. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol 1987, 82:1159-1164.
13. Ventura M.T., Polimeno L., Amoruso A.C., Gatti F., Annoscia E., Marinaro M., et al. Intestinal permeability in patients with adverse reactions to food. Dig Liver Dis 2006, 38:732-736.
14. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
15. Parlesak A., Schafer C., Schutz T., Bode J.C., Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000, 32:742-747.
16. Heller F., Florian P., Bojarski C., Richter J., Christ M., Hillenbrand B., et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005, 129:550-564.
17. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003, 171:6164-6172.
18. Rao R.K., Basuroy S., Rao V.U., Karnaky K.J., Gupta A. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 2002, 368:471-481.
19. Shifflett D.E., Clayburgh D.R., Koutsouris A., Turner J.R., Hecht G.A. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab Invest 2005, 85:1308-1324.
20. Tomson F.L., Koutsouris A., Viswanathan V.K., Turner J.R., Savkovic S.D., Hecht G. Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coli. Gastroenterology 2004, 127:859-869.
21. Li N., Lewis P., Samuelson D., Liboni K., Neu J. Glutamine regulates Caco-2 cell tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2004, 287:G726-733.
22. Seth A., Basuroy S., Sheth P., Rao R.K. l-Glutamine ameliorates acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer. Am J Physiol Gastrointest Liver Physiol 2004, 287:G510-G517.
23. Usami M., Muraki K., Iwamoto M., Ohata A., Matsushita E., Miki A. Effect of eicosapentaenoic acid (EPA) on tight junction permeability in intestinal monolayer cells. Clin Nutr 2001, 20:351-359.
24. Usami M., Komurasaki T., Hanada A., Kinoshita K., Ohata A. Effect of gamma-linolenic acid or docosahexaenoic acid on tight junction permeability in intestinal monolayer cells and their mechanism by protein kinase C activation and/or eicosanoid formation. Nutrition 2003, 19:150-156.
25. Lindmark T., Nikkila T., Artursson P. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 1995, 275:958-964.
26. Chun H., Sasaki M., Fujiyama Y., Bamba T. Effect of enteral glutamine on intestinal permeability and bacterial translocation after abdominal radiation injury in rats. J Gastroenterol 1997, 32:189-195.
27. Xue H., Sawyer M.B., Field C.J., Dieleman L.A., Murray D., Baracos V.E. Bolus oral glutamine protects rats against CPT-11-induced diarrhea and differentially activates cytoprotective mechanisms in host intestine but not tumor. J Nutr 2008, 138:740-746.
28. van der Hulst R.R., van Kreel B.K., von Meyenfeldt M.F., Brummer R.J., Arends J.W., Deutz N.E., et al. Glutamine and the preservation of gut integrity. Lancet 1993, 341:1363-1365.
29. Day A.J., Canada F.J., Diaz J.C., Kroon P.A., McLauchlan R., Faulds C.B., et al. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 2000, 468:166-170.
30. Walgren R.A., Lin J.T., Kinne R.K., Walle T. Cellular uptake of dietary flavonoid quercetin 4′-beta-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther 2000, 294:837-843.
31. Wolffram S., Block M., Ader P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr 2002, 132:630-635.
32. Nemeth K., Plumb G.W., Berrin J.G., Juge N., Jacob R., Naim H.Y., et al. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 2003, 42:29-42.
33. Crespy V., Morand C., Manach C., Besson C., Demigne C., Remesy C. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol 1999, 277:G120-G126.
34. Piskula M.K., Terao J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J Nutr 1998, 128:1172-1178.
35. Radominska-Pandya A., Little J.M., Pandya J.T., Tephly T.R., King C.D., Barone G.W., et al. UDP-Glucuronosyltransferases in human intestinal mucosa. Biochim Biophys Acta 1998, 1394:199-208.
36. Clarke D.B., Lloyd A.S., Botting N.P., Oldfield M.F., Needs P.W., Wiseman H. Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with [13C(3)]isoflavone internal standards. Anal Biochem 2002, 309:158-172.
37. Hollman P.C., Tijburg L.B., Yang C.S. Bioavailability of flavonoids from tea. Crit Rev Food Sci Nutr 1997, 37:719-738.
38. Donovan J.L., Crespy V., Manach C., Morand C., Besson C., Scalbert A., et al. Catechin is metabolized by both the small intestine and liver of rats. J Nutr 2001, 131:1753-1757.
39. O'Leary K.A., Day A.J., Needs P.W., Mellon F.A., O'Brien N.M., Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003, 65:479-491.
40. Matsukawa N., Matsumoto M., Hara H. High biliary excretion levels of quercetin metabolites after administration of a quercetin glycoside in conscious bile duct cannulated rats. Biosci Biotechnol Biochem 2009, 73:1863-1865.
41. Bokkenheuser V.D., Winter J. Hydrolysis of flavonoids by human intestinal bacteria. Prog Clin Biol Res 1988, 280:143-145.
42. Kim D.H., Jung E.A., Sohng I.S., Han J.A., Kim T.H., Han M.J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res 1998, 21:17-23.
43. Aura A.M., O'Leary K.A., Williamson G., Ojala M., Bailey M., Puupponen-Pimia R., et al. Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J Agric Food Chem 2002, 50:1725-1730.
44. Matsukawa N., Matsumoto M., Shinoki A., Hagio M., Inoue R., Hara H. Nondigestible saccharides suppress the bacterial degradation of quercetin aglycone in the large intestine and enhance the bioavailability of quercetin glucoside in rats. J Agric Food Chem 2009.
45. Sakakibara A., Furuse M., Saitou M., Ando-Akatsuka Y., Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 1997, 137:1393-1401.
46. Fujibe M., Chiba H., Kojima T., Soma T., Wada T., Yamashita T., et al. Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp Cell Res 2004, 295:36-47.
47. Elias B.C., Suzuki T., Seth A., Giorgianni F., Kale G., Shen L., et al. Phosphorylation of Y398 and Y402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem 2008.
48. Kale G., Naren A.P., Sheth P., Rao R.K. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun 2003, 302:324-329.
49. Rao R.K., Li L., Baker R.D., Baker S.S., Gupta A. Glutathione oxidation and PTPase inhibition by hydrogen peroxide in Caco-2 cell monolayer. Am J Physiol Gastrointest Liver Physiol 2000, 279:G332-G340.
50. Basuroy S., Sheth P., Kuppuswamy D., Balasubramanian S., Ray R.M., Rao R.K. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem 2003, 278:11916-11924.
51. Atkinson K.J., Rao R.K. Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions. Am J Physiol Gastrointest Liver Physiol 2001, 280:G1280-1288.
52. Sheth P., Seth A., Atkinson K.J., Gheyi T., Kale G., Giorgianni F., et al. Acetaldehyde dissociates the PTP1B-E-cadherin-beta-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism. Biochem J 2007, 402:291-300.
53. Purohit V., Bode J.C., Bode C., Brenner D.A., Choudhry M.A., Hamilton F., et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008, 42:349-361.
54. Rao R.K., Seth A., Sheth P. Recent advances in alcoholic liver disease: I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004, 286:G881-G884.
55. Visapaa J.P., Tillonen J., Salaspuro M. Microbes and mucosa in the regulation of intracolonic acetaldehyde concentration during ethanol challenge. Alcohol Alcohol 2002, 37:322-326.
56. Koivisto T., Salaspuro M. Aldehyde dehydrogenases of the rat colon: comparison with other tissues of the alimentary tract and the liver. Alcohol Clin Exp Res 1996, 20:551-555.
57. Rao R.K. Acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer. Alcohol Clin Exp Res 1998, 22:1724-1730.
58. Wells C.L., Jechorek R.P., Kinneberg K.M., Debol S.M., Erlandsen S.L. The isoflavone genistein inhibits internalization of enteric bacteria by cultured Caco-2 and HT-29 enterocytes. J Nutr 1999, 129:634-640.
59. Schmitz H., Fromm M., Bentzel C.J., Scholz P., Detjen K., Mankertz J., et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999, 112(Pt 1):137-146.
60. Suzuki T., Hara H. Quercetin enhances intestinal barrier function through the assembly of zonula occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J Nutr 2009, 139:965-974.
61. Amasheh M., Schlichter S., Amasheh S., Mankertz J., Zeitz M., Fromm M., et al. Quercetin enhances epithelial barrier function and increases claudin-4 expression in Caco-2 cells. J Nutr 2008, 138:1067-1073.
62. Dorfel M.J., Westphal J.K., Huber O. Differential phosphorylation of occludin and tricellulin by CK2 and CK1. Ann N Y Acad Sci 2009, 1165:69-73.
63. Watson J.L., Ansari S., Cameron H., Wang A., Akhtar M., McKay D.M. Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4. Am J Physiol Gastrointest Liver Physiol 2004, 287:G954-G961.
64. Justesen U., Knuthsen P., Leth T. Determination of plant polyphenols in Danish foodstuffs by HPLC-UV and LC-MS detection. Cancer Lett 1997, 114:165-167.
65. Hertog M.G., Hollman P.C., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993, 20:21-29.
66. Sampson L., Rimm E., Hollman P.C., de Vries J.H., Katan M.B. Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 2002, 102:1414-1420.
67. Arts I.C., van de Putte B., Hollman P.C. Catechin contents of foods commonly consumed in The Netherlands: 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem 2000, 48:1746-1751.
68. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans: I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
69. Manach C., Morand C., Texier O., Favier M.L., Agullo G., Demigne C., et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 1995, 125:1911-1922.
70. Matsukawa N., Matsumoto M., Chiji H., Hara H. Oligosaccharide promotes bioavailability of a water-soluble flavonoid glycoside, alpha G-rutin, in rats. J Agric Food Chem 2009, 57:1498-1505.
71. Bronner F. Recent developments in intestinal calcium absorption. Nutr Rev 2009, 67:109-113.
72. Schlingmann K.P., Waldegger S., Konrad M., Chubanov V., Gudermann T. TRPM6 and TRPM7-Gatekeepers of human magnesium metabolism. Biochim Biophys Acta 2007, 1772:813-821.
73. Song Y., Peng X., Porta A., Takanaga H., Peng J.B., Hediger M.A., et al. Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 2003, 144:3885-3894.